Artigo de periodico

All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies (2015)

• Autores:
  • Sanz, Miguel A.
  • Montesinos, Pau
  • Kim, Haesook T.
  • Ruiz-Argüelles, Guillermo J.
  • Undurraga, María S.
  • Uriarte, María R.
  • Martínez, Lem
  • Jacomo, Rafael H.
  • Gutiérrez-Aguirre, Homero
  • Melo, Raul A. M.
  • Bittencourt, Rosane
  • Pasquini, Ricardo
  • Pagnano, Katia - Universidade Estadual de Campinas (UNICAMP)
  • Fagundes, Evandro M.
  • Vallenga, Edo
  • Holowiecka, Alexandra
  • González-Huerta, Ana J.
  • Fernández, Pascual
  • De La Serna, Javier
  • Brunet, Salut
  • De Lisa, Elena
  • González-Campos, José
  • Ribera, José M.
  • Krsnik, Isabel
  • Ganser, Arnold
  • Berliner, Nancy - Harvard University (HU)
  • Ribeiro, Raul C.
  • Lo-Coco, Francesco
  • Löwenberg, Bob
  • Rego, Eduardo Magalhães
• Autor USP: REGO, EDUARDO MAGALHÃES - FMRP
• Unidade: FMRP
• DOI: 10.1007/s00277-015-2393-0
• Assuntos: LEUCEMIA; VITAMINA A; QUIMIOTERÁPICOS
• Idioma: Inglês
• Imprenta:
  • Local: Heidelberg
  • Data de publicação: 2015
• Fonte:
  • Título do periódico: Annals of Hematology
  • ISSN: 0939-5555
  • Volume/Número/Paginação/Ano: v. 94, n. 8, p. 1347-1356, 2015

Informações sobre o DOI: 10.1007/s00277-015-2393-0 (Fonte: oaDOI API)
• Este periódico é de assinatura
• Este artigo NÃO é de acesso aberto
  
• Cor do Acesso Aberto: closed

---

Como citar

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  SANZ, Miguel A. et al. All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies. Annals of Hematology, v. 94, n. 8, p. 1347-1356, 2015Tradução . . Disponível em: https://doi.org/10.1007/s00277-015-2393-0. Acesso em: 19 set. 2024.

• APA

  Sanz, M. A., Montesinos, P., Kim, H. T., Ruiz-Argüelles, G. J., Undurraga, M. S., Uriarte, M. R., et al. (2015). All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies. Annals of Hematology, 94( 8), 1347-1356. doi:10.1007/s00277-015-2393-0

• NLM

  Sanz MA, Montesinos P, Kim HT, Ruiz-Argüelles GJ, Undurraga MS, Uriarte MR, Martínez L, Jacomo RH, Gutiérrez-Aguirre H, Melo RAM, Bittencourt R, Pasquini R, Pagnano K, Fagundes EM, Vallenga E, Holowiecka A, González-Huerta AJ, Fernández P, De La Serna J, Brunet S, De Lisa E, González-Campos J, Ribera JM, Krsnik I, Ganser A, Berliner N, Ribeiro RC, Lo-Coco F, Löwenberg B, Rego EM. All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies [Internet]. Annals of Hematology. 2015 ; 94( 8): 1347-1356.[citado 2024 set. 19 ] Available from: https://doi.org/10.1007/s00277-015-2393-0

• Vancouver

  Sanz MA, Montesinos P, Kim HT, Ruiz-Argüelles GJ, Undurraga MS, Uriarte MR, Martínez L, Jacomo RH, Gutiérrez-Aguirre H, Melo RAM, Bittencourt R, Pasquini R, Pagnano K, Fagundes EM, Vallenga E, Holowiecka A, González-Huerta AJ, Fernández P, De La Serna J, Brunet S, De Lisa E, González-Campos J, Ribera JM, Krsnik I, Ganser A, Berliner N, Ribeiro RC, Lo-Coco F, Löwenberg B, Rego EM. All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies [Internet]. Annals of Hematology. 2015 ; 94( 8): 1347-1356.[citado 2024 set. 19 ] Available from: https://doi.org/10.1007/s00277-015-2393-0

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• Trangenic mice expressing hCG-NuMA-RAR'alfa' develop hematopoietic abnormalities leading to acute promyelocytic leukemia
• Role od promyelocytic leukemia (PML) protein in tumor suppression
• Estudo da relevância da inativação do CCAAT enhancer binding protein 'alfa' (C/EBP'alfa') na gênese da leucemia promielocítica
• Linfomas não Hodgkin de células T maduras e de células NK extramodais
• Identification of myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia
• Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression-free survival in multiple myeloma
• Association between the TP53 Arg72Pro polymorphism and clinical outcomes in acute myeloid leukemia
• Florence: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk
• Anemia e palidez
• Temporal trends in Hematopoietic Stem Cell Transplantation in Argentina. [Editorial]: regional differences that mirror the global reality